- Saturday, November 11, 2023
6:30 AM – 7:45 AM ET
Breakfast Activity/Non-CE-Accredited Satellite Symposium
Clinical Considerations for the Treatment of mTNBC and HR+/HER2- mBC with an ADC
Gilead
Seating available on first-come, first-served basis
Seating available on first-come, first-served basis
6:30 AM – 7:45 AM ET
Breakfast Activity/Non-CE-Accredited Satellite Symposium
Clinical Considerations for the Treatment of mTNBC and HR+/HER2- mBC with an ADC
Gilead
Seating available on first-come, first-served basis
Location: Magnolia 10
6:30 AM – 7:45 AM ET
Breakfast Activity/Non-CE-Accredited Satellite Symposium: A first in-class NME in 3L+ follicular lymphoma & A Fixed-Duration Treatment Option for 3L+ Diffuse Large B-Cell Lymphoma
Genentech
Seating available on first-come, first-served basis
6:30 AM – 7:45 AM ET
Breakfast Activity/Non-CE-Accredited Satellite Symposium: A first in-class NME in 3L+ follicular lymphoma & A Fixed-Duration Treatment Option for 3L+ Diffuse Large B-Cell Lymphoma
Genentech
Seating available on first-come, first-served basis
Location: Magnolia 16
6:30 AM – 7:45 AM ET
Breakfast Activity/Non-CE-Accredited Satellite Symposium: Learn more about a CAR T cell therapy for relapsed/refractory multiple myeloma (RRMM)
Bristol Myers Squibb
Seating available on first-come, first served basis
6:30 AM – 7:45 AM ET
Breakfast Activity/Non-CE-Accredited Satellite Symposium: Learn more about a CAR T cell therapy for relapsed/refractory multiple myeloma (RRMM)
Bristol Myers Squibb
Seating available on first-come, first served basis
Location: Magnolia 13
6:30 AM – 7:45 AM ET
Breakfast Activity/Non-CE-Accredited Satellite Symposium: Myelofibrosis and Strategies for Disease Management: Key Considerations for Patient Care
GSK
Seating available on first-come, first served basis
6:30 AM – 7:45 AM ET
Breakfast Activity/Non-CE-Accredited Satellite Symposium: Myelofibrosis and Strategies for Disease Management: Key Considerations for Patient Care
GSK
Seating available on first-come, first served basis
Location: Magnolia 19
6:30 AM – 6:30 PM ET
Registration
6:30 AM – 6:30 PM ET
Registration
Location: Cypress Registration
7:00 AM – 8:00 AM ET
Exhibit Hall Open & Continental Breakfast
7:00 AM – 8:00 AM ET
Exhibit Hall Open & Continental Breakfast
Location: Cypress 2
8:00 AM – 8:15 AM ET
Opening Remarks & APSHO Fellow (FAPO) Recognition Presentation
8:00 AM – 8:10 AM ET
Opening Remarks & APSHO Fellow (FAPO) Recognition PresentationLocation: Cypress 1Live Stream
8:10 AM – 8:30 AM ET
The Mary Pazdur Award Presentation
8:10 AM – 8:25 AM ET
The Mary Pazdur Award PresentationLocation: Cypress 1Live Stream
8:25 AM – 9:00 AM ET
The Annual Mary Pazdur Award Recipient Lecture
8:25 AM – 9:00 AM ET
The Annual Mary Pazdur Award Recipient LectureLocation: Cypress 1Speaker: – Memorial Sloan Kettering Cancer Center
Live Stream
Kelly Haviland, PhD, RN, FNP-BC, TGNB-C – Memorial Sloan Kettering Cancer Center ### 1634899###Speaker######Memorial Sloan Kettering Cancer Center###Speaker: – Memorial Sloan Kettering Cancer Center
###
9:15 AM – 10:15 AM ET
Essence of Surgical Oncology: Knowing When and When Not to Operate on Patients With Cancer
9:15 AM – 10:15 AM ET
Essence of Surgical Oncology: Knowing When and When Not to Operate on Patients With CancerLocation: RoyalSpeaker: – University of Texas MD Anderson Cancer Center
Steven H. Wei, EdD, MPH, MS, PA-C, DFAAPA (he/him/his) – University of Texas MD Anderson Cancer Center ### 285342###Speaker###APP Manager###University of Texas MD Anderson Cancer Center###Speaker: – University of Texas MD Anderson Cancer Center
### he/him/his
9:15 AM – 10:15 AM ET
New Drug Updates: Solid Tumors
9:15 AM – 10:15 AM ET
New Drug Updates: Solid TumorsLocation: Cypress 1Speaker: – University of Connecticut School of Pharmacy
Live Stream
Lisa M. Holle, PharmD, BCOP, FHOPA, FISOPP – University of Connecticut School of Pharmacy ### 2055503###Speaker###Clinical Professor###University of Connecticut School of Pharmacy###Speaker: – University of Connecticut School of Pharmacy
###
10:15 AM – 11:15 AM ET
Exhibit Hall Open & Refreshment Break
10:15 AM – 11:15 AM ET
Exhibit Hall Open & Refreshment Break
Location: Cypress 2
10:15 AM – 11:15 AM ET
Moderated Posters: Clinical Posters, Industry Encore Posters, and APSHO Patient Perspective Posters
10:15 AM – 11:15 AM ET
Moderated Posters: Clinical Posters, Industry Encore Posters, and APSHO Patient Perspective Posters
Location: Cypress 2
10:15 AM – 6:15 PM ET
Braindate
10:15 AM – 6:15 PM ET
Braindate
Location: Cypress 2 Alcove - Braindate Lounge
10:30 AM – 11:00 AM ET
APSHO Committee Meet & Greet: Membership Committee
10:30 AM – 11:00 AM ET
APSHO Committee Meet & Greet: Membership Committee
Location: Cypress Alcove 1 - APSHO Booth
10:30 AM – 11:00 AM ET
Exhibit Hall Presentation
The FIRST and ONLY Therapy Approved for Adults with Indolent Systemic Mastocystosis (ISM)
Blueprint Medicines
10:30 AM – 11:00 AM ET
Exhibit Hall Presentation
The FIRST and ONLY Therapy Approved for Adults with Indolent Systemic Mastocystosis (ISM)
Blueprint Medicines
Location: Cypress 2 - Presentation Theater 2
10:30 AM – 11:00 AM ET
Exhibit Hall Presentation
Understanding the role of Advanced Practice Providers in the management of Low-risk Myelodysplastic Syndromes (MDS)
Bristol Myers Squibb
10:30 AM – 11:00 AM ET
Exhibit Hall Presentation
Understanding the role of Advanced Practice Providers in the management of Low-risk Myelodysplastic Syndromes (MDS)
Bristol Myers Squibb
Location: Cypress 2 - Presentation Theater 1
10:30 AM – 11:00 AM ET
Exhibit Hall Presentation: An Overview of Clinical Data for ENHERTU® (fam-trastuzumab deruxtecan-nxki) in 2L HER2+ Metastatic Breast Cancer
Daiichi-Sankyo
10:30 AM – 11:00 AM ET
Exhibit Hall Presentation: An Overview of Clinical Data for ENHERTU® (fam-trastuzumab deruxtecan-nxki) in 2L HER2+ Metastatic Breast Cancer
Daiichi-Sankyo
Location: Cypress 2 - Presentation Theater 3
11:15 AM – 12:15 PM ET
Benign Hematology Limbo: How Low Is Too Low?
11:15 AM – 12:15 PM ET
Benign Hematology Limbo: How Low Is Too Low?Location: RoyalSpeaker: – Cleveland Clinic
Peter Hakos, PA-C – Cleveland Clinic ### 2098773###Speaker###Physician Assistant in Benign Hematology###Cleveland Clinic###Speaker: – Cleveland Clinic
###
11:15 AM – 12:15 PM ET
Improving Outcomes for Women with Metastatic HER2-Positive Breast Cancer
11:15 AM – 12:15 PM ET
Improving Outcomes for Women with Metastatic HER2-Positive Breast CancerLocation: Cypress 1Speaker: – Legoretta Cancer Center at Brown University
Lifespan Cancer Institute
Speaker: – Sarah Cannon Cancer Institute at HCA Midwest Health
Speaker: – Lifespan
Live Stream
Stephanie L. Graff, MD, FACP (she/her/hers) – Legoretta Cancer Center at Brown University
Lifespan Cancer Institute ### 2125285###Speaker###Associate Professor
Director of Breast Oncology###Legoretta Cancer Center at Brown University
Lifespan Cancer Institute###Speaker: – Legoretta Cancer Center at Brown University
Lifespan Cancer Institute
### she/her/hers @@@ Jeanine R. Showalter, MSN, APRN, FNP-BC, AOCNP (she/her/hers) – Sarah Cannon Cancer Institute at HCA Midwest Health ### 2129222###Speaker###Nurse Practitioner###Sarah Cannon Cancer Institute at HCA Midwest Health###Speaker: – Sarah Cannon Cancer Institute at HCA Midwest Health
### she/her/hers @@@ Christine McGinn, MSN, APRN, ACNP-BC (she/her/hers) – Lifespan ### 2134903###Speaker###Oncology NP###Lifespan###Speaker: – Lifespan
### she/her/hers
12:15 PM – 1:45 PM ET
Exhibit Hall & Lunch
12:15 PM – 1:45 PM ET
Exhibit Hall & Lunch
Location: Cypress 2
12:15 PM – 1:45 PM ET
Lunch Activity/Non-CE-Accredited Satellite Symposium: A Discussion of a Real-world Patient Case of Chronic GVHD -- Intervene at the First Signs of Initial Systemic Treatment Failure
Incyte
Seating available on first-come, first served basis
12:15 PM – 1:45 PM ET
Lunch Activity/Non-CE-Accredited Satellite Symposium: A Discussion of a Real-world Patient Case of Chronic GVHD -- Intervene at the First Signs of Initial Systemic Treatment Failure
Incyte
Seating available on first-come, first served basis
Location: Magnolia 16
12:15 PM – 1:45 PM ET
Lunch Activity/Non-CE-Accredited Satellite Symposium: An FDA approved treatment option for anemia in LR-MDS
Bristol Myers Squibb
Seating available on first-come, first served basis
12:15 PM – 1:45 PM ET
Lunch Activity/Non-CE-Accredited Satellite Symposium: An FDA approved treatment option for anemia in LR-MDS
Bristol Myers Squibb
Seating available on first-come, first served basis
Location: Magnolia 13
12:15 PM – 1:45 PM ET
Lunch Activity/Non-CE-Accredited Satellite Symposium: Dual Immunotherapy + Platinum-Based Chemotherapy for the Treatment of mNSCLCm & Treatment Option for Unresectable Hepatocellular Carcinoma
AstraZeneca
Seating is available on first-come, first-served basis
12:15 PM – 1:45 PM ET
Lunch Activity/Non-CE-Accredited Satellite Symposium: Dual Immunotherapy + Platinum-Based Chemotherapy for the Treatment of mNSCLCm & Treatment Option for Unresectable Hepatocellular Carcinoma
AstraZeneca
Seating is available on first-come, first-served basis
Location: Magnolia 19
12:15 PM – 1:45 PM ET
Lunch Activity/Non-CE-Accredited Satellite Symposium: Treatment of Adults with Certain BRAF Mutation Positive Metastatic Cancers
Pfizer Oncology
Seating is available on first-come, first-served basis
12:15 PM – 1:45 PM ET
Lunch Activity/Non-CE-Accredited Satellite Symposium: Treatment of Adults with Certain BRAF Mutation Positive Metastatic Cancers
Pfizer Oncology
Seating is available on first-come, first-served basis
Location: Magnolia 10
12:30 PM – 1:00 PM ET
APSHO Committee Meet & Greet: Meet the APSHO Board of Directors
12:30 PM – 1:00 PM ET
APSHO Committee Meet & Greet: Meet the APSHO Board of Directors
Location: Cypress Alcove 1 - APSHO Booth
1:15 PM – 1:45 PM ET
APSHO Committee Meet & Greet: Professional Development & Leadership Committee (PD&L)
1:15 PM – 1:45 PM ET
APSHO Committee Meet & Greet: Professional Development & Leadership Committee (PD&L)
Location: Cypress Alcove 1 - APSHO Booth
1:45 PM – 2:45 PM ET
Staying Abreast of New Biomarkers in Hematology/Oncology
1:45 PM – 2:45 PM ET
Staying Abreast of New Biomarkers in Hematology/OncologyLocation: Cypress 1Speaker: – Fred Hutchinson Cancer Center / UW Medicine
Speaker: – Cincinnati Cancer Advisors
Live Stream
Grace Baek, PharmD, BCOP – Fred Hutchinson Cancer Center / UW Medicine ### 2098774###Speaker###Clinical Hematology/Oncology Pharmacist###Fred Hutchinson Cancer Center / UW Medicine###Speaker: – Fred Hutchinson Cancer Center / UW Medicine
### @@@ Andrew S. Guinigundo, MSN, RN, CNP, ANP-BC (he/him/his) – Cincinnati Cancer Advisors ### 285272###Speaker###Director of Precision Oncology###Cincinnati Cancer Advisors###Speaker: – Cincinnati Cancer Advisors
### he/him/his
1:45 PM – 2:45 PM ET
Supportive Care and Coordination of Patients Receiving Immune Effector Cell Therapies: Strategies for Advanced Practitioners
1:45 PM – 2:45 PM ET
Supportive Care and Coordination of Patients Receiving Immune Effector Cell Therapies: Strategies for Advanced PractitionersLocation: RoyalSpeaker: – Medical College of Georgia
Speaker: – Georgia Cancer Center/ Wellstar MCGHealth
Stephanie Daniels, PA-C – Medical College of Georgia ### 2130878###Speaker###Bone Marrow Transplant and Cellular Therapy Programs###Medical College of Georgia ###Speaker: – Medical College of Georgia
### @@@ Shreya Desai, MD (she/her/hers) – Georgia Cancer Center/ Wellstar MCGHealth ### 2130879###Speaker###PGY-5 Physician###Georgia Cancer Center/ Wellstar MCGHealth###Speaker: – Georgia Cancer Center/ Wellstar MCGHealth
### she/her/hers
2:45 PM – 3:45 PM ET
Exhibit Hall Open & Refreshment Break
2:45 PM – 3:45 PM ET
Exhibit Hall Open & Refreshment Break
Location: Cypress 2
3:00 PM – 3:30 PM ET
APSHO Committee Meet & Greet: Research & Quality Improvement Committee (RQI)
3:00 PM – 3:30 PM ET
APSHO Committee Meet & Greet: Research & Quality Improvement Committee (RQI)
Location: Cypress Alcove 1 - APSHO Booth
3:00 PM – 3:30 PM ET
Exhibit Hall Presentation
Janssen invites you to learn more about a treatment option for patients diagnosed with Multiple Myeloma who are Relapsed/Refractory and have received >=4 prior lines of therapyJanssen Oncology part of the Pharmaceutical Companies of Johnson & Johnson
3:00 PM – 3:30 PM ET
Exhibit Hall Presentation
Janssen invites you to learn more about a treatment option for patients diagnosed with Multiple Myeloma who are Relapsed/Refractory and have received >=4 prior lines of therapyJanssen Oncology part of the Pharmaceutical Companies of Johnson & Johnson
Location: Cypress 2 - Presentation Theater 2
3:00 PM – 3:30 PM ET
Exhibit Hall Presentation: Discover a treatment option for certain patients with ESR1-mutated mBC
Stemline Therapeutics
3:00 PM – 3:30 PM ET
Exhibit Hall Presentation: Discover a treatment option for certain patients with ESR1-mutated mBC
Stemline Therapeutics
Location: Cypress 2 - Presentation Theater 3
3:00 PM – 3:30 PM ET
Exhibit Hall Presentation: Practical Management of AML with a BCL2 Inhibitor
AbbVie, US Medical Affairs
3:00 PM – 3:30 PM ET
Exhibit Hall Presentation: Practical Management of AML with a BCL2 Inhibitor
AbbVie, US Medical Affairs
Location: Cypress 2 - Presentation Theater 1
3:45 PM – 4:45 PM ET
New Drug Updates: Investigational Therapeutics in the Pipeline
3:45 PM – 4:45 PM ET
New Drug Updates: Investigational Therapeutics in the PipelineLocation: Cypress 1Live Stream
Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP – UI Health ### 1778358###Speaker###Clinical Associate Professor###UI Health###Speaker: – UI Health
###
3:45 PM – 4:45 PM ET
What’s Circulating? The Future of Cancer Detection and Treatment
3:45 PM – 4:45 PM ET
What’s Circulating? The Future of Cancer Detection and TreatmentLocation: RoyalSpeaker: – University of Kentucky Markey Cancer Center
Speaker: – University of Kentucky Markey Cancer Center
Holly R. Chitwood, DNP, APRN, FNP-C, AGACNP-BC (she/her/hers) – University of Kentucky Markey Cancer Center ### 861296###Speaker###Assistant Professor###University of Kentucky Markey Cancer Center###Speaker: – University of Kentucky Markey Cancer Center
### she/her/hers @@@ Adria Myers, DNP, APRN, AOCNP (she/her/hers) – University of Kentucky Markey Cancer Center ### 863155###Speaker###Advanced Practice Provider II###University of Kentucky Markey Cancer Center###Speaker: – University of Kentucky Markey Cancer Center
### she/her/hers
3:45 PM – 5:00 PM ET
AP Talk: Peer Roundtables
3:45 PM – 5:00 PM ET
AP Talk: Peer RoundtablesLocation: Magnolia 13Moderator: – Medical Strategy Consultant
Speaker: – Clinical Medical Director, University Medical Center of El Paso Palliative Care
Speaker: – University of Colorado, Anschutz Medical Center
Speaker: – Memorial Sloan Kettering Cancer Center
Speaker: – Memorial Sloan Kettering Cancer Center
Speaker: – UPMC Hillman Cancer Center
Speaker: – Abramson Cancer Center
Speaker: – Texas Oncology Baylor Sammons Cancer Center
Speaker: – University of North Carolina Chapel Hill School of Nursing and Lineberger Comprehensive Cancer Center.
Speaker: – City of Hope
Speaker: – City of Hope
Lindsey M. Lyle, MS, PA-C – Medical Strategy Consultant ### 294851###Moderator###Physician Assistant###Medical Strategy Consultant###Moderator: – Medical Strategy Consultant
### @@@ Jeanne Lee, MD – Clinical Medical Director, University Medical Center of El Paso Palliative Care ### 2075546###Speaker###Author, "Own Your Care: A Family Guide..."###Clinical Medical Director, University Medical Center of El Paso Palliative Care###Speaker: – Clinical Medical Director, University Medical Center of El Paso Palliative Care
### @@@ Judy R. Knudson, MPAS, PA-C, BSN – University of Colorado, Anschutz Medical Center ### 2075545###Speaker###Assistant Professor ###University of Colorado, Anschutz Medical Center ###Speaker: – University of Colorado, Anschutz Medical Center
### @@@ Kelly Haviland, PhD, RN, FNP-BC, TGNB-C – Memorial Sloan Kettering Cancer Center ### 1634899###Speaker######Memorial Sloan Kettering Cancer Center###Speaker: – Memorial Sloan Kettering Cancer Center
### @@@ Jibran Majeed, DNP, ACNP-BC, CCRN – Memorial Sloan Kettering Cancer Center ### 2168369###Speaker###Advanced Practice Provider Manager and Regional UCC/SCC and Emergency Response###Memorial Sloan Kettering Cancer Center###Speaker: – Memorial Sloan Kettering Cancer Center
### @@@ Debra Evans, MSN, ANP-BC, AOCNP – UPMC Hillman Cancer Center ### 1807934###Speaker######UPMC Hillman Cancer Center###Speaker: – UPMC Hillman Cancer Center
### @@@ Carolyn Grande, CRNP – Abramson Cancer Center ### 407708###Speaker###Nurse Practitioner###Abramson Cancer Center###Speaker: – Abramson Cancer Center
### @@@ Katie Bukolt, MSN, FNP-C, AOCNP – Texas Oncology Baylor Sammons Cancer Center ### 607323###Speaker###Nurse Practitioner###Texas Oncology Baylor Sammons Cancer Center###Speaker: – Texas Oncology Baylor Sammons Cancer Center
### @@@ Lorinda A. Coombs, PhD, CNS, FNP-BC, AOCNP® – University of North Carolina Chapel Hill School of Nursing and Lineberger Comprehensive Cancer Center. ### 1806536###Speaker###Assistant Professor###University of North Carolina Chapel Hill School of Nursing and Lineberger Comprehensive Cancer Center.###Speaker: – University of North Carolina Chapel Hill School of Nursing and Lineberger Comprehensive Cancer Center.
### @@@ Kathleen D. Burns, AGACNP-BC, OCN – City of Hope ### 567805###Speaker###Nurse Practitioner ###City of Hope###Speaker: – City of Hope
### @@@ Mai-An Pham, PharmD – City of Hope ### 2179130###Speaker######City of Hope###Speaker: – City of Hope
###
5:00 PM – 5:45 PM ET
Independent Certified Satellite Symposium Current and Emerging Treatment Strategies in Multiple Myeloma
5:00 PM – 5:45 PM ET
Independent CE-Accredited Satellite SymposiumRefractory/Resistant Multiple Myeloma: The Ever-Changing Therapeutic LandscapeLocation: Sago
5:45 PM – 6:30 PM ET
>Independent Certified Satellite Symposium The Role of APs in the Treatment of NSCLC: Facilitating Effective Multidisciplinary Patient Management Strategies
5:45 PM – 6:30 PM ET
Independent CE-Accredited Satellite SymposiumThe Role of APs in the Treatment of NSCLC: Facilitating Effective Multidisciplinary Patient Management StrategiesLocation: Sago
